Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $2,009 | 5 | 59.4% |
| Food and Beverage | $1,372 | 16 | 40.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| CSL Behring | $2,465 | 11 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $415.40 | 5 | $0 (2018) |
| GENZYME CORPORATION | $249.13 | 2 | $0 (2019) |
| Veloxis Pharmaceuticals, Inc. | $190.44 | 2 | $0 (2018) |
| Relypsa, Inc. | $60.43 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $2,465 | 11 | CSL Behring ($2,465) |
| 2019 | $124.94 | 1 | GENZYME CORPORATION ($124.94) |
| 2018 | $430.80 | 4 | Novartis Pharmaceuticals Corporation ($190.72) |
| 2017 | $359.66 | 5 | Novartis Pharmaceuticals Corporation ($224.68) |
All Payment Transactions
21 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/19/2022 | CSL Behring | — | Travel and Lodging | In-kind items and services | $1,010.26 | General |
| 08/19/2022 | CSL Behring | — | Travel and Lodging | In-kind items and services | $166.44 | General |
| 08/19/2022 | CSL Behring | — | Travel and Lodging | Cash or cash equivalent | $54.00 | General |
| 08/18/2022 | CSL Behring | — | Food and Beverage | In-kind items and services | $113.87 | General |
| 08/18/2022 | CSL Behring | — | Food and Beverage | In-kind items and services | $104.69 | General |
| 08/18/2022 | CSL Behring | — | Food and Beverage | Cash or cash equivalent | $60.00 | General |
| 08/17/2022 | CSL Behring | — | Travel and Lodging | In-kind items and services | $611.45 | General |
| 08/17/2022 | CSL Behring | — | Travel and Lodging | In-kind items and services | $166.44 | General |
| 08/17/2022 | CSL Behring | — | Food and Beverage | In-kind items and services | $125.00 | General |
| 08/17/2022 | CSL Behring | — | Food and Beverage | Cash or cash equivalent | $28.42 | General |
| 08/17/2022 | CSL Behring | — | Food and Beverage | Cash or cash equivalent | $24.73 | General |
| 12/15/2019 | GENZYME CORPORATION | THYMOGLOBULIN (Drug) | Food and Beverage | In-kind items and services | $124.94 | General |
| Category: ONCOLOGY | ||||||
| 08/23/2018 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $67.81 | General |
| 06/03/2018 | Novartis Pharmaceuticals Corporation | ZORTRESS (Drug) | Food and Beverage | In-kind items and services | $122.91 | General |
| Category: IMMUNOLOGY | ||||||
| 06/02/2018 | GENZYME CORPORATION | THYMOGLOBULIN (Drug) | Food and Beverage | In-kind items and services | $124.19 | General |
| Category: ONCOLOGY | ||||||
| 01/18/2018 | Veloxis Pharmaceuticals, Inc. | Envarsus XR (SP) (Drug), Envarsus XR, Envarsus XR | Food and Beverage | In-kind items and services | $115.89 | General |
| Category: Immunosuppressant | ||||||
| 09/13/2017 | Relypsa, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $60.43 | General |
| Category: Hyperkalemia | ||||||
| 05/12/2017 | Novartis Pharmaceuticals Corporation | ZORTRESS (Drug) | Food and Beverage | In-kind items and services | $21.20 | General |
| Category: IMMUNOLOGY | ||||||
| 04/30/2017 | Novartis Pharmaceuticals Corporation | ZORTRESS (Drug) | Food and Beverage | In-kind items and services | $114.73 | General |
| Category: IMMUNOLOGY | ||||||
| 04/10/2017 | Veloxis Pharmaceuticals, Inc. | Envarsus XR (Drug), Envarsus XR, Envarsus XR | Food and Beverage | In-kind items and services | $74.55 | General |
| Category: Immunosuppressant | ||||||
| 04/06/2017 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $88.75 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 193 | 341 | $94,675 | $29,808 |
| 2022 | 6 | 286 | 563 | $151,624 | $45,820 |
| 2021 | 8 | 361 | 724 | $199,675 | $61,283 |
| 2020 | 11 | 407 | 666 | $173,308 | $51,003 |
All Medicare Procedures & Services
31 procedure records from CMS Medicare Utilization — Page 2 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90945 | Dialysis procedure including one evaluation | Facility | 2020 | 16 | 28 | $5,939 | $1,887 | 31.8% |
| 99496 | Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge | Facility | 2020 | 15 | 15 | $8,249 | $1,838 | 22.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 29 | 33 | $5,280 | $1,272 | 24.1% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2020 | 19 | 21 | $3,675 | $1,182 | 32.2% |
| 90935 | Hemodialysis procedure with one physician evaluation | Facility | 2020 | 19 | 19 | $3,870 | $1,093 | 28.2% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2020 | 13 | 13 | $1,950 | $477.60 | 24.5% |
About Dr. Eric Langewisch, M.D
Dr. Eric Langewisch, M.D is a Nephrology healthcare provider based in Omaha, Nebraska. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/16/2007. The National Provider Identifier (NPI) number assigned to this provider is 1366576662.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eric Langewisch, M.D has received a total of $3,381 in payments from pharmaceutical and medical device companies, with $2,465 received in 2022. These payments were reported across 21 transactions from 5 companies. The most common payment nature is "Travel and Lodging" ($2,009).
As a Medicare-enrolled provider, Langewisch has provided services to 1,247 Medicare beneficiaries, totaling 2,294 services with total Medicare billing of $187,913. Data is available for 4 years (2020–2023), covering 31 distinct procedure/service records.
Practice Information
- Specialty Nephrology
- Other Specialties Internal Medicine
- Location Omaha, NE
- Active Since 03/16/2007
- Last Updated 08/06/2016
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1366576662
Products in Payments
- ZORTRESS (Drug) $258.84
- THYMOGLOBULIN (Drug) $249.13
- Envarsus XR (SP) (Drug) $115.89
- Envarsus XR (Drug) $74.55
- Veltassa (Drug) $60.43
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Omaha
Richard Lund, M.d, M.D
Nephrology — Payments: $364,423
Dr. Jeffrey Passer, Md, MD
Nephrology — Payments: $119,054
Roslyn Mannon, M.d, M.D
Nephrology — Payments: $64,489
Dr. Stefan Hemmings, M.b., B.s, M.B., B.S
Nephrology — Payments: $4,386
Jerry Fischer, Md, Phd, MD, PHD
Nephrology — Payments: $3,680
Sunil Jagadesh, Md, MD
Nephrology — Payments: $3,648